Overview
This prospective longitudinal interventional study aims to evaluate the effect of structured peri-procedural nursing interventions on resilience and anxiety in men undergoing transrectal prostate biopsy. Participants will receive a standardized nursing intervention before and after the biopsy procedure. Resilience, anxiety, pain, lower urinary tract symptoms, and perceived nursing support will be assessed at predefined time points. Histopathological findings (benign or malignant) will be used for subgroup analyses. The study is conducted at the University Clinical Hospital Mostar, Bosnia and Herzegovina.
Description
This is a prospective, single-center, longitudinal interventional study conducted at the Department of Urology, University Clinical Hospital Mostar, Bosnia and Herzegovina.
The objective is to determine whether structured peri-procedural nursing interventions improve resilience and reduce anxiety in men undergoing transrectal prostate biopsy.
Participants will be assessed at three time points:
- baseline before the biopsy,
- 0-24 Houra after the procedure
- 2-3 weeks after the biopsy after receiving histopathological results. The study outcomes include resilience, anxiety, pain, lower urinary tract symptoms, and patients perception of nursing support.
Histopathological disgnosis (benign or malignant) will be used for subgroup analyses.
Approximately 120-140 participants are expected to be enrolled, with an anticipated final sample of approximately 100-110 participants after follow-up.
Eligibility
Inclusion Criteria:
- Male participants aged 40 years or older.
- Scheduled for transrectal ultrasound-guided prostate biopsy because of suspected prostate cancer.
- Able to understand the study procedures and provide written informed consent.
- Willing to complete all study assessments during the follow-up period.
Exclusion Criteria:
- Inabillity to provide informed consent.
- Severe cognitive impairment or psychiatric disorder preventing questionnaire completion.
- Previous disgnosis of prostate cancer.
- Inabillity to complete follow-up assessments.
- Withdrawal of informed consent at any time.
